• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Aktiia Secures $42M for Blood Pressure Intelligence Platform, Rebrands to Hilo

by Syed Hamza Sohail 05/01/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

–  Aktiia, a blood pressure intelligence platform, announces an oversubscribed $42 million Series B funding round, co-led by Earlybird Health and Wellington Partners, with new investors Kfund and NaturalX Health Ventures, and participation from existing investors redalpine, Khosla Ventures, Molten Ventures, Translink Capital and Verve Ventures.

– The investment, which has brought the total financing to date above $100 million, will accelerate the company’s mission to manage the world’s blood pressure. 

Hilo Secures Series B Funding to Advance Cuffless Blood Pressure Monitoring Technology and Global Expansion

Hilo, formerly known as Aktiia, has announced the close of its Series B funding round, marking a significant milestone in its journey to revolutionize blood pressure monitoring. This funding will drive product innovation, accelerate international expansion, and support the development of its enterprise-focused blood pressure intelligence platform.

The latest investment builds on a period of rapid progress for the company, during which it has:

  • Achieved 76% compounded annual revenue growth
  • Secured CE marking for its mobile phone camera-based blood pressure monitoring technology
  • Gained regulatory approvals in Canada, Australia, and Saudi Arabia
  • Completed a pivotal clinical trial in preparation for its U.S. FDA application

As part of this next phase of growth, the company has introduced a new brand identity—Hilo—reflecting its global ambition to make cuffless, clinically validated blood pressure monitoring universally accessible and effortless. This rebrand marks a strategic evolution, aligning with Hilo’s vision of enabling healthier blood pressure for all, while continuing to deliver the trusted technology and clinically relevant reporting for which the company is known.

To date, Hilo has sold over 120,000 devices and established itself as a leader in the emerging cuffless blood pressure monitoring (CBPM) category. Its proprietary foundation machine learning model is specifically trained for blood pressure assessment, drawing on:

  • Tens of billions of optical signals from real-world users
  • Hundreds of millions of calibration points to ensure precision and reliability

Commenting on the announcement, Hilo CEO Raghav “Rags” Gupta emphasized that the Series B round affirms investor confidence in Hilo’s technology and mission. He noted that with billions of people worldwide affected by hypertension—and only 20% achieving adequate control—the need for more accessible, accurate, and convenient monitoring solutions is urgent. The rebrand to Hilo, he added, represents a broader commitment to global health empowerment through intelligent, user-centered tools.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Oracle Health Launches AI Center of Excellence for Healthcare

Oracle Health Launches AI Center of Excellence for Healthcare

Particle Health Addresses Integration to Epic Data Despite Dispute

US Court Allows Particle’s Antitrust Claims Against Epic to Proceed

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

Sage Growth Partners Report: Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |